川宁生物 (301301.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(川宁生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 1,523,218,164.004,823,335,006.683,581,333,354.272,417,199,192.701,269,733,317.683,820,657,857.712,939,569,616.721,983,863,175.58-
 营业利润(元) 423,227,499.001,121,399,685.69776,737,673.12475,357,061.84213,237,446.52545,121,086.88433,774,118.84279,919,282.08-
 利润总额(元) 421,919,620.051,117,711,071.63768,589,525.85469,760,439.79210,385,110.93487,631,575.28389,811,184.19278,580,881.56-
 净利润(元) 352,626,111.92940,564,996.29640,149,589.72390,868,667.86175,446,681.52411,517,362.46332,291,056.73237,152,526.45-
 归属于母公司股东的净利润(元) 352,614,874.42940,563,998.57640,149,778.46390,868,667.97175,446,682.72411,518,024.65332,291,748.85237,153,026.36-
盈利能力:
 销售毛利率(%) 34.4231.5729.9328.4026.1624.8028.2528.5526.65
 销售净利率(%) 23.1519.5017.8716.1713.8210.7711.3011.9510.09
 净资产收益率(%) 5.1514.2910.896.86-----
 总资产报酬率ROA(%) 4.2011.488.295.19-----
 投入资本回报率ROIC(%) 3.8510.136.964.301.884.513.772.72-
营运能力:
 存货周转率(次) 0.822.162.531.61-----
 应收账款周转率(次) 1.655.933.622.53-----
 总资产周转率(次) 0.150.470.370.25-----
偿债能力:
 资产负债率(%) 30.6531.2233.6534.4336.8640.2346.5846.98-
 股东权益比率(%) 69.2368.6566.2465.5063.0859.7153.3652.96-
 已获利息倍数(倍) 34.3119.3718.4117.179.774.965.335.33-
 流动比率 1.761.561.621.571.681.671.651.55-
 速动比率 1.160.881.111.141.191.130.980.94-
发展能力:
 营业收入增长率(%) 19.9626.2421.8321.8427.3418.2115.83-12.76
 营业利润增长率(%) 98.48105.7279.0769.8277.89143.7796.22108.6362.04
 税后利润增长率(%) 100.98128.5692.6564.8274.41269.5893.31103.4774.10
 净资产增长率(%) 14.7412.1830.3427.67-30.045.62--
 总资产增长率(%) 4.55-2.424.993.21-9.82-1.73--

前瞻产业研究院